Abstract:Objective The purpose of this study was to investigate the clinical significance of serum vascular endothelial growth factor(S-VEGF)in patients of esophageal squamous cell carcinoma with the end-point of progress-free survival rate.Methods Sera from 89 patients with esophageal squamous carcinoma,who presented and treated with concurrent chemoradiotherapy or surgical resection in Cancer Center d Sun Yat-Sen University from December 2002 to May 2004,were sampled at the time of pre-treatment.30 cases of health individuals without any evidence of disease were selected as control group.For patients with surgical resection were performed with esophagectomy and extended lymphadenectomy.For patients with concurrent chemoradiotherapy comprised of cisplatin and 5-fluorouracil.The radiotherapy dose of 2 Gy per day was initiated on Day 1 of chemotherapy and continued daily for 5 days per week for 6 weeks,for a total close of 60 Gy.Two courses of chemotherapy were given during radiotherapy at 6-week intervals.The serum vascular endothelial growth factor(S- VEGF)levels were measured with a solid phase enzyme Human VEGF Immunoassay ELISA kit.The end point of this study was progress-free survival,and time was calculated from the date of diagnosis to date of relapse or last follow evaluation.Results S-VEGF level of patients with esophageal squamous cell carcinoma was significantly higher than that of heahhy controls(475.93±44.76 pg/ml vs.294.20±23.40 pg/ml;P=0.020).S-VEGF levels in patients with StageⅢand StageⅣdisease were significantly higher than those in patients with Stage I and StageⅡdisease.The 1-year progress-free survival rate d high S-VEGF group(≥475 pg/ml)was significantly lower than that of the low S-VEGF group(＜475 pg/ml)(24% vs.66%;P=0.0004).The 1-year progress-free survival rate of the patients with StageⅠand StageⅡdisease was significantly higher than that of patients with StageⅢand StageⅣdisease(71% vs.29%;P=0.0015).The variables were assessed by multivariate analysis using the Cox proportional hazards model,and the results revealed that the clinical stage and the S-VEGF were first and second independent prognosis factor,respectively.Conclusions In the current study,a high S-VEGF was found to be associated with tumor progression,poor treatment response,and poor survival in patients with squamous cell carcinoma of the esophagus.

Expression of Vascular Endothelial Growth Factor Mrna in Esophageal Carcinoma and Preliminary Inquiry into Its Clinical Significance

Expression of Human Vascular Endothelial Growth Factor in Ampullary Carcinoma and Its Significance

Significance of Vascular Endothelial Growth Factor Expression and Its Correlation with Inducible Nitric Oxide Synthase in Gastric Cancer

The Correlation Between Expression of Vascular Endothelial Growth Factor and Invasiveness and Metastasis of Gastric Carcinoma

Vascular Endothelial Growth Factor Expression in Primary Esophageal Carcinoma

Expression of vascular endothelial growth factor and proliferation cell nuclear antigen in esophageal carcinoma treated by radiotherapy

The Expression and Clinical Significance of Vascular Endothelial Growth Factor-C in Gastric Cancer Tissues

Expression of vascular endothelial growth factor and its correlation with clinicopathologi-cal characteristics in esophageal squamous cell cancer

Clinical Significance of VEGF and MVD Expression in Esophageal Carcinomas

Expression and clinical study of vascular endothelial growth factor and its receptors FLT-1, FLK-1/KDR in non-small cell lung cancer

VEGF-C Expression and Clinical Significance in Esophageal Squamous Cell Carcinoma

[VEGF-C Mrna Expression and Its Relationship with Clinicopathological Parameters in Esophageal Squamous Cell Carcinoma].

Correlation between Vascular Endothelial Growth Factor Expression and Prognosis of Esophageal Cancer: A Meta-Analysis

Expression and clinicopathological significance of VEGF -C in esophageal squamous cell carcinoma

Prognostic significance of vascular endothelial growth factor expression in esophageal carcinoma: a meta-analysis.

Expressions of Vascular Endothelial Growth Factor and Non-Metastasis 23 in Eesophageal Squamous Cell Carcinoma and Their Clinical Significance

Expression of vascular endothelial growth factor and Survivin in esophageal cancer and their relations with pathological manifestation

Expression and Clinical Significance of Vascular Endothelial Growth Factor in Rectal Cancers

Clinical Significance of S-VEGF in Patients with Esophageal Cancer

Expression of VEGF-C correlates with a poor prognosis based on analysis of prognostic factors in 73 patients with esophageal squamous cell carcinomas.

Expression of Vascular Endothelial Factor in Human Colorectal Cancer and Its Clinical Significance